Navigation Links
AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs
Date:7/23/2008

WILMINGTON, Del., July 23 /PRNewswire-FirstCall/ -- More than a third of the people who contacted AstraZeneca (NYSE: AZN) to inquire about the company's prescription savings programs learned of the programs from their doctors or pharmacists, according to a year-long survey of more than 12,000 patients.

The survey found that 35 percent of the patients who called AstraZeneca's information center regarding prescription savings programs said they were referred by healthcare professionals. Another 14 percent learned of the program from brochures, which also are available in doctors' offices, hospitals, clinics and pharmacies.

"AstraZeneca understands that our medicines don't do patients any good if they cannot afford to pay for them," said Tony Zook, President and CEO, AstraZeneca North America. "We connect families with our patient assistance programs in a variety of ways, but our most valuable tool is providing doctors and pharmacists with the information they need to help their patients."

As they meet with healthcare providers, AstraZeneca's pharmaceutical sales specialists share up-to-date clinical information on medicines and other issues impacting patient care, including adherence, educational materials and prescription savings programs.

The study's data shows that the message on patient assistance programs is getting through in a variety of ways. AstraZeneca asked 12,487 patients who contacted its information center between April 2007 and March 2008 where they learned about the company's patient assistance programs. The results:

-- Doctor/pharmacist 35 percent

-- Brochure 14 percent

-- Advertising 9 percent

-- AZ Web sites 7 percent

<
'/>"/>
SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca
2. Cellectricon and AstraZeneca - Partners in New High Throughput Ion Channel Drug Discovery Technology
3. WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
4. AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers
5. Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
6. AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer by 2016
7. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
8. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
9. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
10. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
11. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013  MacroGenics, Inc. today announced that an ... an Fc-modified chimeric monoclonal antibody (MAb), in patients ... will be presented at the 2013 Annual Meeting ... the Developmental Therapeutics - Immunotherapy Oral Abstract Session ... PM.  The presentation will describe the results of ...
(Date:5/21/2013)...  Personal Genome Diagnostics Inc. (PGDx), today announced ... expertise in genomic analysis of defined cancer subtypes ... Blueprint Medicines.  PGDx is an innovator in conducting ... tumors, and Blueprint Medicines is an expert in ... defined patient population. "This collaboration brings ...
(Date:5/21/2013)... 2013 Revolutionary Science, the manufacturer of ... announced today that they have expanded their colony counter ... IncuCount, IntelliCount, InCount and ImpressCount. These affordable colony ... useful in food microbiology and pharmaceutical manufacturing. , The ... A bright white enclosure with jet black accents ...
(Date:5/21/2013)... Mississauga, Ontario (PRWEB) May 21, 2013 ... expert scientists of the ITN to design the ... usefulness of two key clinical models used in ... Chamber (EEC) and Nasal Allergen Challenge (NAC) models. ... supported by numerous publications, to date no direct ...
Breaking Biology Technology:MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
... HARBIN, China, April 15 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, ... CSKI ), a,leading fully integrated pharmaceutical company ... today announced record,financial results for the fourth quarter and ... Fourth Quarter 2008 Highlights, -- ...
... Inc. (Nasdaq: VTIV ) today announced that it ... conference call on Friday, May 8, 2009 at 8:30 a.m. ... listen, please dial 800-358-8448 (Domestic) or (706) 634-1367 (International). The ... at http://www.inventivhealth.com/about_us/n_webcasts.aspx . To listen, ...
... OmniComm Systems, Inc. (OTC Bulletin Board: OMCM) announced that ... LLC for the purpose of resolving the patent infringement ... entered into a licensing arrangement with DataSci. OmniComm ... have come to an agreement in this matter. ...
Cached Biology Technology:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 2China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 3China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 4China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 5China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 6China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 7China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 8China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 9China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 10inVentiv Health to Announce First Quarter 2009 Results and Conduct Conference Call on Friday, May 8 2OmniComm Systems Announces Settlement of Patent Litigation With DataSci, LLC 2
(Date:5/21/2013)... the body, stem cells in the blood often ... mature immune cells that can fight off illness. ... cell populations, potentially leading to the development of ... team of researchers led by biologists at the ... in mouse models, the molecule microRNA-146a (miR-146a) acts ...
(Date:5/21/2013)... Cancers of all types become most deadly when ... cancer has reached this stage, it becomes very difficult ... that can develop. Now, researchers at the University of ... that target lymphoma tumor cells wherever they may be ... oncology in the MU College of Veterinary Medicine, says ...
(Date:5/21/2013)... College of Medicine will study gender differences in how the ... -- and how changes in fat metabolism play a role ... from the National Heart, Lung and Blood Institute. , When ... These changes may play a major role in the development ... says E. Douglas Lewandowski, director of the UIC Center for ...
Breaking Biology News(10 mins):Keeping stem cells strong 2MU researchers develop radioactive nanoparticles that target cancer cells 2Do men's and women's hearts burn fuel differently? 2
... Some bacteria react to the cold by subtly changing the ... as temperatures drop. Scientists identified a key protein in this ... how bacteria sense cold in the first place remained a ... and Argentina,s National University of Rosario, the answer is: They ...
... species may play highly important but vastly underrecognized ... group of evolutionary biologists suggests in a study. ... may be forcing these mutualist systems down unprecedented ... change can happen very rapidly, over a few ...
... hold increasing promise as a cure for multiple diseases. But ... flip side, as faulty regulation of stem cells leads to ... made by the stem cells of the foetus are a ... by the body losing control of stem cell function. Guiding ...
Cached Biology News:Bacteria gauge cold with molecular measuring stick 2From bees to coral reefs: How humans impact partnerships in the natural world 2From bees to coral reefs: How humans impact partnerships in the natural world 3From bees to coral reefs: How humans impact partnerships in the natural world 4From bees to coral reefs: How humans impact partnerships in the natural world 5Shock tactics: Bioelectrical therapy for cancer and birth defects? 2
Reacts with methylated DNA from plants and vertebrates...
Mouse monoclonal [GB3] to Kalinin ( Abpromise for all tested applications). entrezGeneID: 3918 SwissProtID: Q13753...
Rabbit polyclonal to Tryptophanyl tRNA synthetase ( Abpromise for all tested applications). Antigen: Recombinant full length protein (Human): Tryptophanyl tRNA synthetase Entrez Gene ID: 745...
Mouse monoclonal [CIa] to Ia Antigen (Biotin) ( Abpromise for all tested applications)....
Biology Products: